Dermata Therapeutics, Inc. (DRMA)

Nasdaq · Pharmaceutical Preparations · Inc. DE

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 1 signal for Dermata Therapeutics, Inc.. Most notable: 2026-08-17: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing material agreement
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change
  4. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2026-06-16Scott Kathleen D.directorS111.19$13
2026-02-17Bedoya-Toro Munera Maria EofficerP1,0001.27$1,270
2025-12-23Van Hoose Kyri K.officerA122,549——
2025-12-23PROEHL GERALD TdirectorA122,549——
2025-12-23PROEHL GERALD TdirectorA490,196——
2025-01-23HALE DAVID FdirectorA78,741——
2025-01-21FISHER MARYdirectorA196,851——
2025-01-21Van Hoose Kyri K.officerA78,741——
2025-01-21PROEHL GERALD TdirectorA787,402——

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings